FORTE BIOSCIENCES, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
FORTE BIOSCIENCES, INC. (FBRX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $15.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
- FORTE BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $15.00M, a 154.24% increase from fiscal 2024.
- FORTE BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $5.90M, a 7.81% decline from fiscal 2023.
- FORTE BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $6.40M, a 146.15% increase from fiscal 2022.
- FORTE BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $2.60M, a 31.58% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $15.00M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $5.90M 10-K · filed 2026-03-31 | |
| 2023-12-31 | $6.40M 10-K · filed 2025-03-28 | |
| 2022-12-31 | $2.60M 10-K · filed 2024-03-18 | |
| 2021-12-31 | $3.80M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $4.40M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $1.10M 10-K · filed 2021-03-16 | -$700.00K 10-K · filed 2020-02-27 |
| 2018-12-31 | $2.60M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $400.00K 10-K · filed 2019-02-27 | |
| 2016-12-31 | $400.00K 10-K · filed 2018-03-09 |